In consultation: Guidance and quality standards
Showing 1 to 3 of 3
Title | Consultation | Type | Consultation end date |
---|---|---|---|
Zilucoplan for treating antibody positive generalised myasthenia gravis [ID4008] | Draft guidance | Technology appraisal guidance | |
Lisocabtagene maraleucel for treating relapsed or refractory large B-cell lymphomas after first-line chemotherapy when a stem cell transplant is suitable [ID3887] | Draft guidance | Technology appraisal guidance | |
Fenfluramine for treating seizures associated with Lennox–Gastaut syndrome in people 2 years and over [ID1651] | Draft guidance | Technology appraisal guidance |